PLUR
Pluri Inc

5,638
Loading...
Loading...
Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The firm focuses on the research, development, and manufacturing of cell-based products and technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
127

Frequently Asked Questions

What is Market Cap of Pluri Inc?
What is the 52-week high for Pluri Inc?
What is the 52-week low for Pluri Inc?
What is Pluri Inc stock price today?
What was Pluri Inc stock price yesterday?
What is the PE ratio of Pluri Inc?
What is the Price-to-Book ratio of Pluri Inc?
What is the 50-day moving average of Pluri Inc?
How many employess does Pluri Inc has?

Latest PLUR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.